Alzheimer’s Research Papers~ October 2002 ~ Beta Amyloid Blog

Alzheimer’s Research Papers~ October 2002 ~ Beta Amyloid Blog    

           

Kranenburg O, Bouma B, Kroon-Batenburg LM, Reijerkerk A, Wu YP, Voest EE, Gebbink MF. Tissue-type plasminogen activator is a multiligand cross-beta structure receptor. Curr Biol. 2002 Oct 29;12(21):1833-9.

Kim HS, Lee JH, Lee JP, Kim EM, Chang KA, Park CH, Jeong SJ, Wittendorp MC, Seo JH, Choi SH, Suh YH. Amyloid beta peptide induces cytochrome C release from isolated mitochondria. Neuroreport. 2002 Oct 28;13(15):1989-93.

Chételat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport. 2002 Oct 28;13(15):1939-43.

 

Stenh C, Nilsberth C, Hammarbäck J, Engvall B, Näslund J, Lannfelt L. The Arctic mutation interferes with processing of the amyloid precursor protein. Neuroreport. 2002 Oct 28;13(15):1857-60.

Finucane TE. Cholinesterase inhibitors for Alzheimer's disease. Lancet. 2002 Oct 26;360(9342):1332; discussion 1332-3.

Hou L, Kang I, Marchant RE, Zagorski MG. Methionine 35 oxidation reduces fibril assembly of the amyloid abeta-(1-42) peptide of Alzheimer's disease. J Biol Chem. 2002 Oct 25;277(43):40173-6.

Selkoe DJ. Alzheimer's disease is a synaptic failure. Science. 2002 Oct 25;298(5594):789-91.

 

Takahashi S, Yonezawa H, Takahashi J, Kudo M, Inoue T, Tohgi H. Selective reduction of diffusion anisotropy in white matter of Alzheimer disease brains measured by 3.0 Tesla magnetic resonance imaging. Neurosci Lett. 2002 Oct 25;332(1):45-8.

Opazo C, Huang X, Cherny RA, Moir RD, Roher AE, White AR, Cappai R, Masters CL, Tanzi RE, Inestrosa NC, Bush AI. Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2). J Biol Chem. 2002 Oct 25;277(43):40302-8.

Wenk GL, Rosi S, McGann K, Hauss-Wegrzyniak B. A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat. Eur J Pharmacol. 2002 Oct 25;453(2-3):319-24.

Apelt J, Kumar A, Schliebs R. Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein. Brain Res. 2002 Oct 25;953(1-2):17-30.

Lüth HJ, Münch G, Arendt T. Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation. Brain Res. 2002 Oct 25;953(1-2):135-43.

 

Török M, Milton S, Kayed R, Wu P, McIntire T, Glabe CG, Langen R. Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling. J Biol Chem. 2002 Oct 25;277(43):40810-5.

 

Xiong ZQ, McNamara JO. Fleeting activation of ionotropic glutamate receptors sensitizes cortical neurons to complement attack. Neuron. 2002 Oct 24;36(3):363-74.

Tandon A, Fraser P. The presenilins. Genome Biol. 2002 Oct 23;3(11):reviews3014.

Liu F, Iqbal K, Grundke-Iqbal I, Gong CX. Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta. FEBS Lett. 2002 Oct 23;530(1-3):209-14.

Squitti R, Lupoi D, Pasqualetti P, Dal Forno G, Vernieri F, Chiovenda P, Rossi L, Cortesi M, Cassetta E, Rossini PM. Elevation of serum copper levels in Alzheimer's disease. Neurology. 2002 Oct 22;59(8):1153-61. ,

Bennett DA, McDermott MP. Cerebrospinal fluid shunting for Alzheimer's disease? Neurology. 2002 Oct 22;59(8):1126-7.

    

Fassbender K, Stroick M, Bertsch T, Ragoschke A, Kuehl S, Walter S, Walter J, Brechtel K, Muehlhauser F, von Bergmann K, Lütjohann D. Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide. Neurology. 2002 Oct 22;59(8):1257-8. ,

 

Silverberg GD, Levinthal E, Sullivan EV, Bloch DA, Chang SD, Leverenz J, Flitman S, Winn R, Marciano F, Saul T, Huhn S, Mayo M, McGuire D. Assessment of low-flow CSF drainage as a treatment for AD: results of a randomized pilot study. Neurology. 2002 Oct 22;59(8):1139-45.

    

Lawrence DM. Promising developments in Alzheimer's immunotherapy. Lancet. 2002 Oct 19;360(9341):1227.

Steiner H, Winkler E, Edbauer D, Prokop S, Basset G, Yamasaki A, Kostka M, Haass C. PEN-2 is an integral component of the gamma-secretase complex required for coordinated expression of presenilin and nicastrin. J Biol Chem. 2002 Oct 18;277(42):39062-5.

 

Hayes A, Thaker U, Iwatsubo T, Pickering-Brown SM, Mann DM. Pathological relationships between microglial cell activity and tau and amyloid beta protein in patients with Alzheimer's disease. Neurosci Lett. 2002 Oct 18;331(3):171-4.

Varesio E, Rudaz S, Krause KH, Veuthey JL. Nanoscale liquid chromatography and capillary electrophoresis coupled to electrospray mass spectrometry for the detection of amyloid-beta peptide related to Alzheimer's disease. J Chromatogr A. 2002 Oct 18;974(1-2):135-42.

del Ser T. [Dementia with Lewy bodies. Pure and mixed forms] Rev Neurol. 2002 Oct 16;35(8):761-5.

Becker JT, Overman AA. [The semantic memory deficit in Alzheimer's disease] Rev Neurol. 2002 Oct 16;35(8):777-83.

Hamilton RL. [Recent advances in the neuropathological evaluation of Alzheimer s disease: the importance of a synuclein] Rev Neurol. 2002 Oct 16;35(8):765-7.

DeKosky S. [Neurobiology and molecular biology of Alzheimer's disease] Rev Neurol. 2002 Oct 16;35(8):752-60.

Ogawa O, Zhu X, Perry G, Smith MA. Mitochondrial abnormalities and oxidative imbalance in neurodegenerative disease. Sci Aging Knowledge Environ. 2002 Oct 16;2002(41):pe16.

Pope SK, Shue VM, Beck C. Will a Healthy Lifestyle Help Prevent Alzheimer's Disease? Annu Rev Public Health. 2002 Oct 16;

Zhang Y, Mei P, Lou R, Zhang MQ, Wu G, Qiang B, Zhang Z, Shen Y. Gene expression profiling in developing human hippocampus. J Neurosci Res. 2002 Oct 15;70(2):200-8.

Tatebayashi Y, Miyasaka T, Chui DH, Akagi T, Mishima K, Iwasaki K, Fujiwara M, Tanemura K, Murayama M, Ishiguro K, Planel E, Sato S, Hashikawa T, Takashima A. Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau. Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13896-901. ,

 

Tucker HM, Kihiko-Ehmann M, Estus S. Urokinase-type plasminogen activator inhibits amyloid-beta neurotoxicity and fibrillogenesis via plasminogen. J Neurosci Res. 2002 Oct 15;70(2):249-55.

 

Minagar A, Shapshak P, Fujimura R, Ownby R, Heyes M, Eisdorfer C. The role of macrophage/microglia and astrocytes in the pathogenesis of three neurologic disorders: HIV-associated dementia, Alzheimer disease, and multiple sclerosis. J Neurol Sci. 2002 Oct 15;202(1-2):13-23.

Jarriault S, Greenwald I. Suppressors of the egg-laying defective phenotype of sel-12 presenilin mutants implicate the CoREST corepressor complex in LIN-12/Notch signaling in C. elegans. Genes Dev. 2002 Oct 15;16(20):2713-28.

Okochi M, Steiner H, Fukumori A, Tanii H, Tomita T, Tanaka T, Iwatsubo T, Kudo T, Takeda M, Haass C. Presenilins mediate a dual intramembranous gamma-secretase cleavage of Notch-1. EMBO J. 2002 Oct 15;21(20):5408-16.

 

Shea TB, Rogers E, Ashline D, Ortiz D, Sheu MS. Apolipoprotein E deficiency promotes increased oxidative stress and compensatory increases in antioxidants in brain tissue. Free Radic Biol Med. 2002 Oct 15;33(8):1115-20.

Zatta P, Ibn-Lkhayat-Idrissi M, Zambenedetti P, Kilyen M, Kiss T. In vivo and in vitro effects of aluminum on the activity of mouse brain acetylcholinesterase. Brain Res Bull. 2002 Oct 15;59(1):41-5.

Vickers JC, Craig JE, Stankovich J, McCormack GH, West AK, Dickinson JL, McCartney PJ, Coote MA, Healey DL, Mackey DA. The apolipoprotein epsilon4 gene is associated with elevated risk of normal tension glaucoma. Mol Vis. 2002 Oct 14;8:389-93.

Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, Bossini A, Fagard R, Gil-Extremera B, Laks T, Kobalava Z, Sarti C, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Birkenhäger WH, Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002 Oct 14;162(18):2046-52.

López S, Bastida J, Viladomat F, Codina C. Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts. Life Sci. 2002 Oct 11;71(21):2521.

Sharma M, Gupta Y. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci. 2002 Oct 11;71(21):2489.

Rensink AA, Verbeek MM, Otte-Höller I, ten Donkelaar HT, de Waal RM, Kremer B. Inhibition of amyloid-beta-induced cell death in human brain pericytes in vitro. Brain Res. 2002 Oct 11;952(1):111-21.

Salmon DP, Thomas RG, Pay MM, Booth A, Hofstetter CR, Thal LJ, Katzman R. Alzheimer's disease can be accurately diagnosed in very mildly impaired individuals. Neurology. 2002 Oct 8;59(7):1022-8.

 

Chiti F, Calamai M, Taddei N, Stefani M, Ramponi G, Dobson CM. Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases. Proc Natl Acad Sci U S A. 2002 Oct 8;

Storandt M, Grant EA, Miller JP, Morris JC. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology. 2002 Oct 8;59(7):1034-41. ,

 

Ho GJ, Hansen LA, Alford MF, Foster K, Salmon DP, Galasko D, Thal LJ, Masliah E. Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease. Neuroreport. 2002 Oct 7;13(14):1825-8.

Ishihara R, Ide-Ektessabi A, Ikeda K, Mizuno Y, Fujisawa S, Takeuchi T, Ohta T. Investigation of cellular metallic elements in single neurons of human brain tissues. Neuroreport. 2002 Oct 7;13(14):1817-20.

Wang SS, Becerra-Arteaga A, Good TA. Development of a novel diffusion-based method to estimate the size of the aggregated Abeta species responsible for neurotoxicity. Biotechnol Bioeng. 2002 Oct 5;80(1):50-9.

Qin XR, Abe H, Nakanishi H. NMR and CD studies on the interaction of Alzheimer beta-amyloid peptide (12-28) with beta-cyclodextrin. Biochem Biophys Res Commun. 2002 Oct 4;297(4):1011-15.

Compton D, Wavrant DeVriéze F, Petersen RC, Tangalos E, Li L, Hardy J. Possible association between genetic variability at the apolipoprotein(a) locus and Alzheimer's disease in apolipoprotein E2 carriers. Neurosci Lett. 2002 Oct 4;331(1):60-2. , ,

Ishunina T, Wouda J, Fisser B, Swaab D. Sex differences in estrogen receptor alpha and beta expression in vasopressin neurons of the supraoptic nucleus in elderly and Alzheimer's disease patients: no relationship with cytoskeletal alterations. Brain Res. 2002 Oct 4;951(2):322.

Hoozemans J, Veerhuis R, Janssen I, van Elk E, Rozemuller A, Eikelenboom P. The role of cyclo-oxygenase 1 and 2 activity in prostaglandin E(2) secretion by cultured human adult microglia: Implications for Alzheimer's disease. Brain Res. 2002 Oct 4;951(2):218.

Kogen H, Toda N, Tago K, Marumoto S, Takami K, Ori M, Yamada N, Koyama K, Naruto S, Abe K, Yamazaki R, Hara T, Aoyagi A, Abe Y, Kaneko T. Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimer's disease. Org Lett. 2002 Oct 3;4(20):3359-62.

 

Thai DR. Excitatory amino acid transporter EAAT-2 in tangle-bearing neurons in Alzheimer's disease. Brain Pathol. 2002 Oct;12(4):405-11.

Sasaki A, Shoji M, Harigaya Y, Kawarabayashi T, Ikeda M, Naito M, Matsubara E, Abe K, Nakazato Y. Amyloid cored plaques in Tg2576 transgenic mice are characterized by giant plaques, slightly activated microglia, and the lack of paired helical filament-typed, dystrophic neurites. Virchows Arch. 2002 Oct;441(4):358-67.

 

Catani M, Mecocci P, Tarducci R, Howard R, Pelliccioli GP, Mariani E, Metastasio A, Benedetti C, Senin U, Cherubini A. Proton magnetic resonance spectroscopy reveals similar white matter biochemical changes in patients with chronic hypertension and early Alzheimer's disease. J Am Geriatr Soc. 2002 Oct;50(10):1707-10.

Tickoo S, Russell . Drosophila melanogaster as a model system for drug discovery and pathway screening. Curr Opin Pharmacol. 2002 Oct;2(5):555. Abstract

Liu L, Ikonen S, Tapiola T, Tanila H, van Groen T. Fimbria-fornix lesion does not affect APP levels and amyloid deposition in the hippocampus of APP+PS1 double transgenic mice. Exp Neurol. 2002 Oct;177(2):565-74.

Ghoshal N, García-Sierra F, Wuu J, Leurgans S, Bennett DA, Berry RW, Binder LI. Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol. 2002 Oct;177(2):475-93.

 

Mohri T. [Studies on the cytological function of the biomembrane and the neurons] Yakugaku Zasshi. 2002 Oct;122(10):707-26.

Delobel P, Flament S, Hamdane M, Mailliot C, Sambo AV, Bégard S, Sergeant N, Delacourte A, Vilain JP, Buée L. Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis. J Neurochem. 2002 Oct;83(2):412-20.

 

Pitsi D, Kienlen-Campard P, Octave JN. Failure of the interaction between presenilin 1 and the substrate of gamma-secretase to produce Abeta in insect cells. J Neurochem. 2002 Oct;83(2):390-9.

Dixon RM, Bradley KM, Budge MM, Styles P, Smith AD. Longitudinal quantitative proton magnetic resonance spectroscopy of the hippocampus in Alzheimer's disease. Brain. 2002 Oct;125(Pt 10):2332-41.

Clare L, Wilson BA, Carter G, Breen K, Berrios GE, Hodges JR. Depression and anxiety in memory clinic attenders and their carers: implications for evaluating the effectiveness of cognitive rehabilitation interventions. Int J Geriatr Psychiatry. 2002 Oct;17(10):962-7.

Cooper B. Thinking preventively about dementia: a review. Int J Geriatr Psychiatry. 2002 Oct;17(10):895-906.

Ward Robinson J, Halderman S. Perspectives from the World's Largest Alzheimer's Disease Research Conference: Stockholm, Sweden, July 2002. Curr Womens Health Rep. 2002 Oct;2(5):394-6.

Ewbank DC. A multistate model of the genetic risk of Alzheimer's disease. Exp Aging Res. 2002 Oct-Dec;28(4):477-99.

Ikeda M, Brown J, Holland AJ, Fukuhara R, Hodges JR. Changes in appetite, food preference, and eating habits in frontotemporal dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):371-6.

Echeverria V, Cuello AC. Intracellular A-beta amyloid, a sign for worse things to come? Mol Neurobiol. 2002 Oct-Dec;26(2-3):299-316.

Bazan NG, Palacios-Pelaez R, Lukiw WJ. Hypoxia signaling to genes: significance in Alzheimer's disease. Mol Neurobiol. 2002 Oct-Dec;26(2-3):283-98.

Masliah E, Hashimoto M. Development of new treatments for Parkinson's disease in transgenic animal models: a role for beta-synuclein. Neurotoxicology. 2002 Oct;23(4-5):461-8.

Delacourte A, Sergeant N, Wattez A, Maurage CA, Lebert F, Pasquier F, David JP. Tau aggregation in the hippocampal formation: an ageing or a pathological process? Exp Gerontol. 2002 Oct;37(10-11):1291-6.

Tolnay M, Probst A. Frontotemporal lobar degeneration--tau as a pied piper? Neurogenetics. 2002 Oct;4(2):63-75.

 

Bruunsgaard H. Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Netw. 2002 Oct-Dec;13(4):387-2.

Sun YX, Wright HT, Janciauskiene S. Glioma cell activation by Alzheimer's peptide Abeta1-42, alpha1-antichymotrypsin, and their mixture. Cell Mol Life Sci. 2002 Oct;59(10):1734-43.

Shahani N, Brandt R. Functions and malfunctions of the tau proteins. Cell Mol Life Sci. 2002 Oct;59(10):1668-80.

Pasinetti GM. From epidemiology to therapeutic trials with anti-inflammatory drugs in Alzheimer's disease: the role of NSAIDs and cyclooxygenase in beta-amyloidosis and clinical dementia. J Alzheimers Dis. 2002 Oct;4(5):435-45.

Roher AE, Kokjohn TA. Of mice and men: The relevance of transgenic mice Abeta immunizations to Alzheimer's disease. J Alzheimers Dis. 2002 Oct;4(5):431-4.

Otth C, Concha II, Arendt T, Stieler J, Schliebs R, González-Billault C, Maccioni RB. AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. J Alzheimers Dis. 2002 Oct;4(5):417-30.

Kimura T, Fujise N, Ono T, Shono M, Yuzuriha T, Katsuragi S, Takamatsu J, Miyakawa T, Kitamura T. Identification of an aging-related spherical inclusion in the human brain. Pathol Int. 2002 Oct;52(10):636-642.

Chandak GR, Sridevi MU, Vas CJ, Panikker DM, Singh L. Apolipoprotein E and presenilin-1 allelic variation and Alzheimer's disease in India. Hum Biol. 2002 Oct;74(5):683-93. ,

De Ronchi D, Bucchi E, Pederzini M, Scaini S, Petio C, Ferrari G, Dalmonte E. [In Process Citation] Epidemiol Psichiatr Soc. 2002 Oct-Dec;11(4):258-65.

Stazi MA, Cotichini R, Patriarca V, Brescianini S, Fagnani C, D'Ippolito C, Cannoni S, Ristori G, Salvetti M. The Italian Twin Project: from the personal identification number to a national twin registry. Twin Res. 2002 Oct;5(5):382-6.

Ober BA. RT and non-RT methodology for semantic priming research with Alzheimer's disease patients: a critical review. J Clin Exp Neuropsychol. 2002 Oct;24(7):883-911.

Limke TL, Rao MS. Neural stem cells in aging and disease. J Cell Mol Med. 2002 Oct-Dec;6(4):475-96.

Erlanger DM, Kaushik T, Broshek D, Freeman J, Feldman D, Festa J. Development and validation of a web-based screening tool for monitoring cognitive status. J Head Trauma Rehabil. 2002 Oct;17(5):458-76.

Memo M, Blandini F, Nappi G, Spano P. Neuroprotection: promise and pitfalls in anti-inflammatory treatment of Alzheimer's disease. Funct Neurol. 2002 Oct-Dec;17(4):175-6.

Sano M. Do dietary antioxidants prevent Alzheimer's disease? Lancet Neurol. 2002 Oct;1(6):342.

Bales KR, Dodart JC, DeMattos RB, Holtzman DM, Paul SM. Apolipoprotein E, amyloid, and Alzheimer disease. Mol Interv. 2002 Oct;2(6):363-75, 339.

Kaufer DI. Cholinesterase-inhibitor Therapy for Dementia: Novel Clinical Substrates and Mechanisms for Treatment Response. CNS Spectr. 2002 Oct;7(10):742-50.

Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M. Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A. 2002 Oct 1;99(20):13217-21.

 

Scott WK, Vance JM, Haines JL, Pericak-Vance MA. Linkage of Parkinsonism and Alzheimer's disease with Lewy body pathology to chromosome 12. Ann Neurol. 2002 Oct;52(4):524; discussion 524.

Eustace A, Coen R, Walsh C, Cunningham CJ, Walsh JB, Coakley D, Lawlor BA. A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease. Int J Geriatr Psychiatry. 2002 Oct;17(10):968-73.

Diehl J, Kurz A. Frontotemporal dementia: patient characteristics, cognition, and behaviour. Int J Geriatr Psychiatry. 2002 Oct;17(10):914-8.

Tickoo S, Russell S. Drosophila melanogaster as a model system for drug discovery and pathway screening. Curr Opin Pharmacol. 2002 Oct;2(5):555-60.

Askanas V, Engel WK. Inclusion-body myositis and myopathies: different etiologies, possibly similar pathogenic mechanisms. Curr Opin Neurol. 2002 Oct;15(5):525-31.

Wolf O, Convit A, Thorn E, de Leon M. Salivary cortisol day profiles in elderly with mild cognitive impairment. Psychoneuroendocrinology. 2002 Oct;27(7):777.

 

Li SJ, Li Z, Wu G, Zhang MJ, Franczak M, Antuono PG. Alzheimer Disease: evaluation of a functional MR imaging index as a marker. Radiology. 2002 Oct;225(1):253-9.

 

Schenk D. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. Nat Rev Neurosci. 2002 Oct;3(10):824-8.

 

Vogelgesang S, Cascorbi I, Schroeder E, Pahnke J, Kroemer HK, Siegmund W, Kunert-Keil C, Walker LC, Warzok RW. Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans. Pharmacogenetics. 2002 Oct 1;12(7):535-41.

Dominici R, Malferrari G, Mariani C, Grimaldi L, Biunno I. The Interleukin 1-beta exonic (+3953) polymorphism does not alter in vitro protein secretion. Exp Mol Pathol. 2002 Oct;73(2):139-41.

Flashman LA. Disorders of awareness in neuropsychiatric syndromes: an update. Curr Psychiatry Rep. 2002 Oct;4(5):346-53.

Wishart HA, Saykin AJ, McAllister TW. Functional magnetic resonance imaging: emerging clinical applications. Curr Psychiatry Rep. 2002 Oct;4(5):338-45.

Olichney JM, Morris SK, Ochoa C, Salmon DP, Thal LJ, Kutas M, Iragui VJ. Abnormal verbal event related potentials in mild cognitive impairment and incipient Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2002 Oct;73(4):377-84.

Yogev-Falach M, Amit T, Bar-Am O, Weinstock M, Youdim MB. Involvement of MAP kinase in the regulation of amyloid precursor protein processing by novel cholinesterase inhibitors derived from rasagiline. FASEB J. 2002 Oct;16(12):1674-6.

Askanas V, Engel WK. Newest Pathogenetic Considerations in Inclusion-body Myositis: Possible Role of Amyloid-beta, Cholesterol, Relation to Aging and to Alzheimer's Disease. Curr Rheumatol Rep. 2002 Oct;4(5):427-33.

Yao ZX, Papadopoulos V. Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity. FASEB J. 2002 Oct;16(12):1677-9.

 

Brownson D, Mabry T, Leslie S. The cycad neurotoxic amino acid, ss-N-methylamino-L-alanine (BMAA), elevates intracellular calcium levels in dissociated rat brain cells. J Ethnopharmacol. 2002 Oct;82(2-3):159.

McIlroy SP, Dynan KB, Lawson JT, Patterson CC, Passmore AP. Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland. Stroke. 2002 Oct;33(10):2351-6. , ,

Kim SY, Caine ED. Utility and limits of the mini mental state examination in evaluating consent capacity in Alzheimer's disease. Psychiatr Serv. 2002 Oct;53(10):1322-4.

Pasquier J, Michel BF, Brenot-Rossi I, Hassan-Sebbag N, Sauvan R, Gastaut JL. Value of (99m)Tc-ECD SPET for the diagnosis of dementia with Lewy bodies. Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1342-8.

Kröger S, Schröder JE. Agrin in the Developing CNS: New Roles for a Synapse Organizer. News Physiol Sci. 2002 Oct;17:207-12.

DeMager PP, Penke B, Walter R, Harkany T, Härtignny W. Pathological peptide folding in Alzheimer's disease and other conformational disorders. Curr Med Chem. 2002 Oct;9(19):1763-80.

Thompson AJ, Barrow CJ. Protein conformational misfolding and amyloid formation: characteristics of a new class of disorders that include Alzheimer's and Prion diseases. Curr Med Chem. 2002 Oct 1;9(19):1751-62.

Matsunaga Y, Ierovnik E, Yamada T, Turk V. Conformational changes preceding amyloid-fibril formation of amyloid-beta and stefin B; parallels in pH dependence. Curr Med Chem. 2002 Oct;9(19):1717-24.

Marriott LK, Hauss-Wegrzyniak B, Benton RS, Vraniak PD, Wenk GL. Long-term estrogen therapy worsens the behavioral and neuropathological consequences of chronic brain inflammation. Behav Neurosci. 2002 Oct;116(5):902-11.

Bresciani LG, Walsh DT, Gentleman SM, Jen LS. Developmental regulation and possible alternative cleavage of presenilin 1 in the rat retina. Mol Cell Neurosci. 2002 Oct;21(2):239-49.

Matsubara-Tsutsui M, Yamagata H, Morishima A, Nakura J, Mitsuda N, Kamino K, Kondo I, Miki T. The 4,752 C/T polymorphism in the presenilin 1 gene increases the risk of Alzheimer's disease in apolipoprotein E4 carriers. Intern Med. 2002 Oct;41(10):823-8. ,

van Horssen J, Wilhelmus MM, Heljasvaara R, Pihlajaniemi T, Wesseling P, de Waal RM, Verbeek MM. Collagen XVIII: a novel heparan sulfate proteoglycan associated with vascular amyloid depositions and senile plaques in Alzheimer's disease brains. Brain Pathol. 2002 Oct;12(4):456-62.

Ayala-Grosso C, Ng G, Roy S, Robertson GS. Caspase-cleaved amyloid precursor protein in Alzheimer's disease. Brain Pathol. 2002 Oct;12(4):430-41.

 

Villa A, Santiago J, García-Silva S, Ruiz-León Y, Pascual A. Serum is required for release of Alzheimer's amyloid precursor protein in neuroblastoma cells. Neurochem Int. 2002 Oct;41(4):261-9.

Bronge L, Wahlund LO, Brauner A, Basun H, Garlind A. White matter lesions and soluble interleukin-1 receptor type II in CSF from demented and non-demented subjects. Neurochem Int. 2002 Oct;41(4):217-22.

Mariani C, Sacco L, Spinnler H, Venneri A. General Knowledge of the World: a standardised assessment. Neurol Sci. 2002 Oct;23(4):161-75.

Kawahata N. [Neuroimaging of Alzheimer disease and vascular dementia] Nippon Hoshasen Gijutsu Gakkai Zasshi. 2002 Oct;58(10):1335-43.

Tolnay M, Sergeant N, Ghestem A, Chalbot S, de Vos RA, Jansen Steur EN, Probst A, Delacourte A. Argyrophilic grain disease and Alzheimer's disease are distinguished by their different distribution of tau protein isoforms. Acta Neuropathol (Berl). 2002 Oct;104(4):425-34.

 

Togo T, Dickson DW. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Acta Neuropathol (Berl). 2002 Oct;104(4):398-402.

 

Ishizawa K, Komori T, Shimazu T, Yamamoto T, Kitamoto T, Shimazu K, Hirose T. Hyperphosphorylated tau deposition parallels prion protein burden in a case of Gerstmann-Sträussler-Scheinker syndrome P102L mutation complicated with dementia. Acta Neuropathol (Berl). 2002 Oct;104(4):342-50.

 

Yokota O, Terada S, Ishizu H, Tsuchiya K, Kitamura Y, Ikeda K, Uéda K, Kuroda S. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC). Acta Neuropathol (Berl). 2002 Oct;104(4):333-41.

Mitchell JL. What We Know About Estrogen's Effect on the Brain. Curr Womens Health Rep. 2002 Oct;2(5):382-9.

Auld DS, Kornecook TJ, Bastianetto S, Quirion R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol. 2002 Oct;68(3):209-45.

Tabira T. [Significance of intracellular A beta in Alzheimer's disease] Nihon Shinkei Seishin Yakurigaku Zasshi. 2002 Oct;22(5):175-80.

Tanaka S. [Gene diagnosis of Alzheimer's disease and Parkinson's disease] Rinsho Byori. 2002 Oct;50(10):965-9.

Strohmeyer R, Ramirez M, Cole GJ, Mueller K, Rogers J. Association of factor H of the alternative pathway of complement with agrin and complement receptor 3 in the Alzheimer's disease brain. J Neuroimmunol. 2002 Oct;131(1-2):135-46.

Mazzola JL, Sirover MA. Alteration of intracellular structure and function of glyceraldehyde-3-phosphate dehydrogenase: a common phenotype of neurodegenerative disorders? Neurotoxicology. 2002 Oct;23(4-5):603-9.

Utsuki T, Shoaib M, Holloway HW, Ingram DK, Wallace WC, Haroutunian V, Sambamurti K, Lahiri DK, Greig NH. Nicotine lowers the secretion of the Alzheimer's amyloid beta-protein precursor that contains amyloid beta-peptide in rat. J Alzheimers Dis. 2002 Oct;4(5):405-15.

Johnson GV, Bailey CD. Tau, where are we now? J Alzheimers Dis. 2002 Oct;4(5):375-98.

Zhao WQ, Ravindranath L, Mohamed AS, Zohar O, Chen GH, Lyketsos CG, Etcheberrigaray R, Alkon DL. MAP kinase signaling cascade dysfunction specific to Alzheimer's disease in fibroblasts. Neurobiol Dis. 2002 Oct;11(1):166-83.

Chan SL, Culmsee C, Haughey N, Klapper W, Mattson MP. Presenilin-1 mutations sensitize neurons to DNA damage-induced death by a mechanism involving perturbed calcium homeostasis and activation of calpains and caspase-12. Neurobiol Dis. 2002 Oct 1;11(1):2-19.

Tsuji T, Shiozaki A, Kohno R, Yoshizato K, Shimohama S. Proteomic profiling and neurodegeneration in Alzheimer's disease. Neurochem Res. 2002 Oct;27(10):1245-53.

 

Mufson EJ, Counts SE, Ginsberg SD. Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease. Neurochem Res. 2002 Oct;27(10):1035-48.

Hollams EM, Giles KM, Thomson AM, Leedman PJ. MRNA stability and the control of gene expression: implications for human disease. Neurochem Res. 2002 Oct;27(10):957-80.

Ling X, Martins RN, Racchi M, Craft S, Helmerhorst E. Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor. J Alzheimers Dis. 2002 Oct;4(5):369-74.

Korchazhkina OV, Ashcroft AE, Kiss T, Exley C. The degradation of Abeta(25-35) by the serine protease plasmin is inhibited by aluminium. J Alzheimers Dis. 2002 Oct;4(5):357-67.

Chauhan NB. Trafficking of intracerebroventricularly injected antisense oligonucleotides in the mouse brain. Antisense Nucleic Acid Drug Dev. 2002 Oct;12(5):353-7.

Wang W, Xie H, Wan Q, Wang L. The cognitive variations among non-dementia elders: from successful aging to mild cognitive impairment. Zhonghua Nei Ke Za Zhi. 2002 Oct;41(10):671-4.

Bertoli Avella AM, Marcheco Teruel B, Llibre Rodriguez JJ, Gomez Viera N, Borrajero Martinez I, Severijnen EA, Joosse M, van Duijn CM, Heredero Baute L, Heutink P. A novel presenilin 1 mutation (L174 M) in a large Cuban family with early onset Alzheimer disease. Neurogenetics. 2002 Oct;4(2):97-104.

Ptok U, Barkow K, Heun R. Fertility and number of children in patients with Alzheimer's disease. Arch Women Ment Health. 2002 Oct;5(2):83-6.

Bonsignore M, Barkow K, Heun R. Possible influence of selection bias on gender differences in the risk of Alzheimer's disease. Arch Women Ment Health. 2002 Oct;5(2):73-7.

Bonelli RM, Aschoff A, Niederwieser G, Heuberger C, Jirikowski G. Cerebrospinal fluid tissue transglutaminase as a biochemical marker for Alzheimer's disease. Neurobiol Dis. 2002 Oct;11(1):106-10. ,

Huang W, Qiu C, Winblad B, Fratiglioni L. Alcohol consumption and incidence of dementia in a community sample aged 75 years and older. J Clin Epidemiol. 2002 Oct;55(10):959-64.

Taylor JL, Kraemer HC, Noda A, Friedman L, Zarcone V, Tinklenberg JR, Yesavage JA. On disentangling States versus traits: demonstration of a new technique using the Alzheimer's disease assessment scale. Alzheimer Dis Assoc Disord. 2002 Oct-Dec;16(4):254-60.

Collette F, Van der Linden M, Delrue G, Salmon E. Frontal hypometabolism does not explain inhibitory dysfunction in Alzheimer disease. Alzheimer Dis Assoc Disord. 2002 Oct-Dec;16(4):228-38.

Barker WW, Luis CA, Kashuba A, Luis M, Harwood DG, Loewenstein D, Waters C, Jimison P, Shepherd E, Sevush S, Graff-Radford N, Newland D, Todd M, Miller B, Gold M, Heilman K, Doty L, Goodman I, Robinson B, Pearl G, Dickson D, Duara R. Relative frequencies of Alzheimer disease, lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the state of Florida brain bank. Alzheimer Dis Assoc Disord. 2002 Oct-Dec;16(4):203-12.

Small DH, Fodero LR. Cholinergic regulation of synaptic plasticity as a therapeutic target in Alzheimer's disease. J Alzheimers Dis. 2002 Oct;4(5):349-55.

Mukherjee A, Hersh LB. Regulation of amyloid beta-peptide levels by enzymatic degradation. J Alzheimers Dis. 2002 Oct;4(5):341-8.

Herrmann N. Cognitive pharmacotherapy of Alzheimer's disease and other dementias. Can J Psychiatry. 2002 Oct;47(8):715-22.

Zeitschel U, Schliebs R, Rossner S, Bigl V, Eschrich K, Bigl M. Changes in activity and expression of phosphofructokinase in different rat brain regions after basal forebrain cholinergic lesion. J Neurochem. 2002 Oct;83(2):371-80.

Kowalik-Jankowska T, Ruta-Dolejsz M, Wisniewska K, Lankiewicz L, Kozlowski H. Possible involvement of copper(II) in Alzheimer disease. Environ Health Perspect. 2002 Oct;110 Suppl 5:869-70.

Bruinzeel W, Yon J, Giovannelli S, Masure S. Recombinant insect cell expression and purification of human beta-secretase (BACE-1) for X-ray crystallography. Protein Expr Purif. 2002 Oct;26(1):139-48.

Chan DK. A new hypothesis (concept) of diagnosing Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 2002 Oct;57(10):M645-7.

Klünemann HH, Fronhöfer W, Wurster H, Fischer W, Ibach B, Klein HE. Alzheimer's second patient: Johann F. and his family. Ann Neurol. 2002 Oct;52(4):520-3.

    

Hogervorst E, Lehmann DJ, Warden DR, Mcbroom J, Smith AD. Apolipoprotein E epsilon4 and testosterone interact in the risk of Alzheimer's disease in men. Int J Geriatr Psychiatry. 2002 Oct 1;17(10):938-40.

Schulz R, O'Brien A, Czaja S, Ory M, Norris R, Martire LM, Belle SH, Burgio L, Gitlin L, Coon D, Burns R, Gallagher-Thompson D, Stevens A. Dementia caregiver intervention research: in search of clinical significance. Gerontologist. 2002 Oct;42(5):589-602.

 

Tanaka Y, Meguro K, Yamaguchi S, Ishii H, Watanuki S, Funaki Y, Yamaguchi K, Yamadori A, Iwata R, Itoh M. Decreased striatal D(2) receptor density associated with severe behavioral abnormality in Alzheimer's disease. Ann Nucl Med. 2002 Oct;17(7):567-573.

Kim S, Nollen EA, Kitagawa K, Bindokas VP, Morimoto RI. Polyglutamine protein aggregates are dynamic. Nat Cell Biol. 2002 Oct;4(10):826-31.

    

Lomas DA, Carrell RW. Serpinopathies and the conformational dementias. Nat Rev Genet. 2002 Oct;3(10):759-68.

Thomas G. Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol. 2002 Oct;3(10):753-66.

Katsuya T, Baba S, Ishikawa K, Mannami T, Fu Y, Inamoto N, Asai T, Fukuda M, Higaki J, Ogata J, Ogihara T. Epsilon 4 allele of apolipoprotein E gene associates with lower blood pressure in young Japanese subjects: the Suita Study. J Hypertens. 2002 Oct;20(10):2017-21.

Levine J, Stahl Z, Sela BA, Gavendo S, Ruderman V, Belmaker RH. Elevated homocysteine levels in young male patients with schizophrenia. Am J Psychiatry. 2002 Oct;159(10):1790-2.

Solomon B. Anti-aggregating antibodies, a new approach towards treatment of conformational diseases. Curr Med Chem. 2002 Oct;9(19):1737-49.

Zhukareva V, Shah K, Uryu K, Braak H, Del Tredici K, Sundarraj S, Clark C, Trojanowski JQ, Lee VM. Biochemical analysis of tau proteins in argyrophilic grain disease, Alzheimer's disease, and Pick's disease : a comparative study. Am J Pathol. 2002 Oct;161(4):1135-41.

 

Cottrell DA, Borthwick GM, Johnson MA, Ince PG, Turnbull DM. The role of cytochrome c oxidase deficient hippocampal neurones in Alzheimer's disease. Neuropathol Appl Neurobiol. 2002 Oct;28(5):390-6.

Fick DM, Agostini JV, Inouye SK. Delirium superimposed on dementia: a systematic review. J Am Geriatr Soc. 2002 Oct;50(10):1723-32.

Robbins TW. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry. Psychopharmacology (Berl). 2002 Oct;163(3-4):362-80.

Fernández A, Maestú F, Amo C, Gil P, Fehr T, Wienbruch C, Rockstroh B, Elbert T, Ortiz T. Focal temporoparietal slow activity in Alzheimer's disease revealed by magnetoencephalography. Biol Psychiatry. 2002 Oct 1;52(7):764-70.

Edland SD, Rocca WA, Petersen RC, Cha RH, Kokmen E. Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol. 2002 Oct;59(10):1589-93.

Cash AD, Perry G, Ogawa O, Raina AK, Zhu X, Smith MA. Is Alzheimer's disease a mitochondrial disorder? Neuroscientist. 2002 Oct 1;8(5):489-96.

Bacskai BJ, Hyman BT. Alzheimer's disease: what multiphoton microscopy teaches us. Neuroscientist. 2002 Oct;8(5):386-90.

Zhu BT. On the mechanism of homocysteine pathophysiology and pathogenesis: a unifying hypothesis. Histol Histopathol. 2002 Oct;17(4):1283-91.

Lanctôt KL, Herrmann N, Eryavec G, van Reekum R, Reed K, Naranjo CA. Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease. Neuropsychopharmacology. 2002 Oct;27(4):646-54.

Burton EJ, Karas G, Paling SM, Barber R, Williams ED, Ballard CG, McKeith IG, Scheltens P, Barkhof F, O'Brien JT. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage. 2002 Oct;17(2):618-30.

Carpentier M, Robitaille Y, DesGroseillers L, Boileau G, Marcinkiewicz M. Declining expression of neprilysin in Alzheimer disease vasculature: possible involvement in cerebral amyloid angiopathy. J Neuropathol Exp Neurol. 2002 Oct;61(10):849-56.

Wu C, Zhou D, Guan Z, Fan J, Qiao Y. [The association between angiotensin I converting enzyme gene polymorphism and Chinese late onset Alzheimer disease] Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2002 Oct;19(5):401-4.

Gazit E. Mechanistic studies of the process of amyloid fibrils formation by the use of peptide fragments and analogues: implications for the design of fibrillization inhibitors. Curr Med Chem. 2002 Oct;9(19):1725-35.

Millien I, Blaizot X, Giffard C, Mézenge F, Insausti R, Baron JC, Chavoix C. Brain glucose hypometabolism after perirhinal lesions in baboons: implications for Alzheimer disease and aging. J Cereb Blood Flow Metab. 2002 Oct;22(10):1248-61.

Tiraboschi P, Hansen LA, Alford M, Merdes A, Masliah E, Thal LJ, Corey-Bloom J. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Arch Gen Psychiatry. 2002 Oct;59(10):946-51.

Hazell AS. Astrocytes and manganese neurotoxicity. Neurochem Int. 2002 Oct;41(4):271-7.

Frisoni GB, Rossi R, Beltramello A. The radial width of the temporal horn in mild cognitive impairment. J Neuroimaging. 2002 Oct;12(4):351-4.

Luedecking-Zimmer E, DeKosky ST, Chen Q, Barmada MM, Kamboh MI. Investigation of oxidized LDL-receptor 1 (OLR1) as the candidate gene for Alzheimer's disease on chromosome 12. Hum Genet. 2002 Oct;111(4-5):443-51. ,

Rao AV, Balachandran B. Role of oxidative stress and antioxidants in neurodegenerative diseases. Nutr Neurosci. 2002 Oct;5(5):291-309.

Abad Santos F, Novalbos J, Gallego Sandin S, Garcia AG. [Treatment of mild cognitive impairment: value of citicoline] Rev Neurol. 2002 Oct 1;35(7):675-82.

Steele J, Caparros-Lefebvre D, Lees A, Sacks O. Progressive supranuclear palsy and its relation to pacific foci of the parkinsonism-dementia complex and Guadeloupean parkinsonism. Parkinsonism Relat Disord. 2002 Oct;9(1):39.

Veerendra Kumar MH, Gupta YK. Intracerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats. Pharmacol Biochem Behav. 2002 Oct;73(3):565-571.

Tsuang DW, Dalan AM, Eugenio CJ, Poorkaj P, Limprasert P, La Spada AR, Steinbart EJ, Bird TD, Leverenz JB. Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families. Arch Neurol. 2002 Oct;59(10):1622-30.

Cui Y, Le Y, Yazawa H, Gong W, Wang JM. Potential role of the formyl peptide receptor-like 1 (FPRL1) in inflammatory aspects of Alzheimer's disease. J Leukoc Biol. 2002 Oct;72(4):628-35.

Leszek J, Inglot AD, Janusz M, Byczkiewicz F, Kiejna A, Georgiades J, Lisowski J. Colostrinin proline-rich polypeptide complex from ovine colostrum--a long-term study of its efficacy in Alzheimer's disease. Med Sci Monit. 2002 Oct;8(10):PI93-6.